A Randomized, Double Blind, Placebo Controlled Pilot Trial of Rituximab for Non-splenectomised Adults With Acute Immune Thrombocytopenic Purpura Receiving Standard Treatment (R-ITP)

Trial Profile

A Randomized, Double Blind, Placebo Controlled Pilot Trial of Rituximab for Non-splenectomised Adults With Acute Immune Thrombocytopenic Purpura Receiving Standard Treatment (R-ITP)

Completed
Phase of Trial: Phase II

Latest Information Update: 16 Apr 2014

At a glance

  • Drugs Rituximab (Primary)
  • Indications Immune thrombocytopenic purpura
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 16 Apr 2014 New trial record
    • 30 May 2012
    • 21 Jul 2010
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top